Chemoinformaics analysis of 1,3,4,6-tetra-o-galloyl-beta-d-glucose
| Molecular Weight | 582.697 | nRot | 8 |
| Heavy Atom Molecular Weight | 544.393 | nRig | 6 |
| Exact Molecular Weight | 582.273 | nRing | 6 |
| Solubility: LogS | -2.356 | nHRing | 2 |
| Solubility: LogP | 3.1 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 81 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 4 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 35 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 24 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 24 |
| nHA | 8 | APOL | 90.8001 |
| nHD | 4 | BPOL | 45.6099 |
| QED | 0.6 |
| Synth | 1.607 |
| Natural Product Likeliness | -1.123 |
| NR-PPAR-gamma | 0.044 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.002 |
| CACO-2 | -4.268 |
| MDCK | 0.0000226 |
| BBB | 0.963 |
| PPB | 0.839674 |
| VDSS | 2.476 |
| FU | 0.157391 |
| CYP1A2-inh | 0.936 |
| CYP1A2-sub | 0.803 |
| CYP2c19-inh | 0.459 |
| CYP2c19-sub | 0.303 |
| CYP2c9-inh | 0.153 |
| CYP2c9-sub | 0.672 |
| CYP2d6-inh | 0.026 |
| CYP2d6-sub | 0.362 |
| CYP3a4-inh | 0.042 |
| CYP3a4-sub | 0.22 |
| CL | 4.573 |
| T12 | 0.533 |
| hERG | 0.065 |
| Ames | 0.017 |
| ROA | 0.363 |
| SkinSen | 0.765 |
| Carcinogencity | 0.09 |
| EI | 0.99 |
| Respiratory | 0.93 |
| NR-Aromatase | 0.037 |
| Antiviral | Yes |
| Prediction | 0.825835 |